共 49 条
- [1] Miller FD(2015)Epidemiology of hepatitis C virus exposure in Egypt: opportunities for prevention and evaluation World J Hepatol 7 2849-2858
- [2] Elzalabany MS(2000)The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt Lancet 355 887-891
- [3] Hussani S(2010)Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt Proceedings of the National Academy of Sciences 107 14757-14762
- [4] Cuadros DF(2003)Overview of injection practices in two governorates in Egypt Tropical Med Int Health 8 234-241
- [5] Frank C(2006)Evolution of infection control in Egypt: achievements and challenges Am J Infect Control 34 193-200
- [6] Mohamed MK(2019)Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001-17 BMC Infect Dis 19 159-9280
- [7] Strickland GT(2014)Epidemiology and natural history of hepatitis C virus infection World J Gastroenterol 20 9270-1652
- [8] Miller F. D.(2016)Safety of direct antiviral agents in the management of hepatitis C Expert Opin Drug Saf 15 1643-267
- [9] Abu-Raddad L. J.(2017)National treatment programme of hepatitis C in Egypt: hepatitis C virus model of care J Viral Hepat 24 262-83
- [10] Talaat M(2011)Multicenter evaluation of a fully automated third-generation anti-HCV antibody screening test with excellent sensitivity and specificity Med Microbiol Immunol 200 77-8